UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - ADURO BIOTECH INC ownership

ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101. A total of 89 filers reported holding ADURO BIOTECH INC in Q2 2018. The put-call ratio across all filers is 1.39 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ownership history of ADURO BIOTECH INC
ValueSharesWeighting
Q3 2019$59,566,000
-30.0%
56,194
+1.7%
0.00%
Q2 2019$85,059,000
-20.0%
55,233
+106.9%
0.00%
Q1 2019$106,266,000
+50.8%
26,7000.0%0.00%
Q4 2018$70,488,000
-64.1%
26,7000.0%0.00%
Q3 2018$196,245,000
+5.0%
26,7000.0%0.00%
Q2 2018$186,900,000
-24.7%
26,7000.0%0.00%
Q1 2018$248,310,000
+150390.9%
26,700
+100.8%
0.00%
Q3 2016$165,000
+10.0%
13,3000.0%0.00%
Q2 2016$150,000
-11.8%
13,3000.0%0.00%
Q1 2016$170,000
-96.9%
13,300
-93.2%
0.00%
-100.0%
Q4 2015$5,533,000
+117.2%
196,631
+134.1%
0.01%
+200.0%
Q2 2015$2,548,00084,0100.00%
Other shareholders
ADURO BIOTECH INC shareholders Q2 2018
NameSharesValueWeighting ↓
BVF INC/IL 745,886$8,503,0001.71%
OAK RIDGE INVESTMENTS LLC 915,134$10,433,0000.34%
Rock Springs Capital Management LP 415,000$4,731,0000.32%
CLOUGH CAPITAL PARTNERS L P 326,400$3,721,0000.25%
NJ State Employees Deferred Compensation Plan 53,300$608,0000.12%
GLOBEFLEX CAPITAL L P 36,200$413,0000.10%
Vident Investment Advisory, LLC 65,874$751,0000.09%
Virtus ETF Advisers LLC 23,109$263,0000.08%
Foundry Partners, LLC 77,452$883,0000.04%
Artal Group S.A. 100,000$1,140,0000.02%
View complete list of ADURO BIOTECH INC shareholders